Related by context. All words. (Click for frequent words.) 72 pomalidomide 71 axitinib 71 vandetanib 70 sunitinib 70 cediranib 70 Torisel 70 tocilizumab 69 bevacizumab Avastin 69 temsirolimus 69 iniparib 69 eltrombopag 68 Hycamtin 68 Votrient 68 sorafenib 68 sorafenib Nexavar 68 pertuzumab 68 mycophenolate mofetil 68 BAY #-# 68 metastatic renal cell carcinoma 68 decitabine 67 adalimumab 67 HuMax EGFr 67 BRIM2 67 regorafenib 67 dasatinib 67 enzastaurin 67 HER2 positive metastatic breast 67 cabazitaxel 67 docetaxel chemotherapy 67 glatiramer acetate 67 sunitinib malate 67 Herceptin trastuzumab 67 forodesine 67 ZOLINZA 67 aflibercept 67 Taxotere ® 67 Dasatinib 67 Targretin 66 ixabepilone 66 olaparib 66 Velcade bortezomib 66 non squamous NSCLC 66 Femara letrozole 66 teriflunomide 66 zalutumumab 66 recurrent glioblastoma multiforme 66 mTOR inhibitor 66 riociguat 66 Treanda 66 figitumumab 66 FTY# 66 Jevtana 66 lapatinib 66 relapsed ovarian cancer 66 azacitidine 66 Gleevec imatinib 66 apremilast 65 cetuximab Erbitux 65 elotuzumab 65 cetuximab 65 abiraterone 65 Arranon 65 ZACTIMA 65 BRAF inhibitor 65 ZD# [001] 65 visilizumab 65 lapatinib Tykerb 65 Fludara 65 ganetespib 65 standard chemotherapy regimen 65 Pemetrexed 65 Tykerb 65 neratinib 65 oral ridaforolimus 65 bosutinib 65 anastrozole 65 Sorafenib 65 trabectedin 65 topotecan 65 vicriviroc 65 nitazoxanide 65 Ceflatonin 65 iclaprim 65 relapsing MS 65 gemcitabine chemotherapy 65 Folotyn 65 Novartis Zometa 65 Aptivus 65 XELOX 65 LY# [003] 65 FOLFIRI 65 Doxil ® 65 intravenous bisphosphonates 65 carboplatin paclitaxel 65 docetaxel Taxotere 65 fingolimod 65 chemoradiotherapy 65 Tasigna nilotinib 64 Amrubicin 64 Xinlay 64 CoFactor 64 glufosfamide 64 atrasentan 64 Sprycel dasatinib 64 mRCC 64 Aplidin 64 angiogenesis inhibitor 64 Promacta 64 Avastin bevacizumab 64 Sutent 64 CIMZIA TM 64 bendamustine 64 elacytarabine 64 FOLFOX 64 TTF Therapy 64 ponatinib 64 ofatumumab 64 tipranavir 64 teriparatide 64 alkylating agent 64 uric acid lowering 64 rFVIIa 64 Vidaza azacitidine 64 ocrelizumab 64 TEMODAL 64 panitumumab Vectibix 64 chlorambucil 64 evaluating tivozanib 64 TroVax ® 64 TORISEL 64 ASA# 64 CR# vcMMAE 64 pemetrexed 64 avosentan 64 docetaxel Taxotere R 64 motesanib 64 ProSavin 64 pegylated interferons 64 phase IIb study 64 OncoVEX GM CSF 64 Pertuzumab 64 fluorouracil 64 zoledronic acid 64 Crestor rosuvastatin 64 Betaferon ® 64 sargramostim 64 gastrointestinal stromal tumors 64 Temsirolimus 64 darapladib 64 bardoxolone methyl 64 tremelimumab 64 Tarceva TM 64 Cimzia 64 monotherapy 64 RoACTEMRA 64 idraparinux 64 T DM1 64 pemetrexed Alimta 64 vorinostat 64 Pazopanib 64 Nexavar sorafenib 64 nilotinib 64 IMA# 64 levosimendan 63 obatoclax 63 metastatic RCC 63 active comparator 63 Campath alemtuzumab 63 Golimumab 63 ACZ# 63 Zolinza 63 neoadjuvant treatment 63 bortezomib Velcade 63 Xyotax 63 sorafenib tablets 63 ritonavir boosted 63 Clolar 63 PROMACTA 63 Taxotere docetaxel 63 cladribine 63 metastatic hormone refractory 63 abatacept 63 DU #b 63 APTIVUS 63 CHOP chemotherapy 63 bevacizumab 63 Vandetanib 63 mitoxantrone 63 pegylated liposomal doxorubicin 63 Taxotere 63 Revlimid lenalidomide 63 boceprevir 63 Traficet EN 63 TNF alpha inhibitor 63 tanespimycin 63 Fablyn 63 deforolimus 63 Actemra 63 MAGE A3 ASCI 63 abiraterone acetate 63 temozolomide 63 Bezielle 63 Ixempra 63 metastatic HRPC 63 YONDELIS 63 AZILECT R 63 letrozole 63 Cimzia ® certolizumab pegol 63 amrubicin 63 canakinumab 63 Tygacil 63 interferon alfa 63 standard chemotherapy regimens 63 Dacogen injection 63 gefitinib Iressa 63 ACTEMRA TM 63 infusional 5-FU/LV 63 Erlotinib 63 pegylated interferon alpha 63 gadobutrol 63 panitumumab 63 rituximab 63 ximelagatran 63 palifosfamide 63 anakinra 63 metastatic renal cell 63 Diovan HCT 63 Yervoy 63 IRESSA 63 PREZISTA r 63 gemcitabine Gemzar 63 XGEVA 63 Onrigin 63 Mylotarg 63 eribulin mesylate 63 thalidomide Thalomid 63 placebo controlled clinical 63 mertansine 63 phase IIb clinical 63 Myfortic 63 romidepsin 63 IRX 2 63 Natalizumab 63 cilengitide 63 Faslodex 63 Zarnestra 63 phase IIb trial 63 Carfilzomib 63 brivaracetam 63 PegIntron 63 bortezomib 63 comparator arm 63 randomized Phase IIb 63 trastuzumab Herceptin 63 Xgeva 63 TYKERB 63 heavily pretreated 63 Egrifta 62 indolent NHL 62 Dapagliflozin 62 boosted protease inhibitor 62 Vectibix 62 recurrent GBM 62 anti TNF 62 Taxol paclitaxel 62 fostamatinib 62 anti leukemic 62 NovoTTF 62 metastatic colorectal cancer 62 ustekinumab 62 APPRAISE 62 Firazyr 62 Cytoxan 62 seliciclib 62 leucovorin 62 abatacept Orencia 62 Fludarabine 62 Roche Pegasys 62 Quinamed 62 trabedersen 62 ACTEMRA 62 perampanel 62 romiplostim 62 interferon therapy 62 metastatic CRC 62 Abatacept 62 HuLuc# 62 pimecrolimus 62 custirsen 62 infliximab Remicade 62 taxane chemotherapy 62 Atacand 62 Allovectin 7 ® 62 Aflibercept 62 HyQ 62 erlotinib Tarceva 62 ELACYT 62 oral Xeloda 62 LymphoStat B 62 CAELYX 62 PXD# 62 gastrointestinal stromal tumors GIST 62 briakinumab 62 FOLFOX6 62 TroVax 62 docetaxel 62 irinotecan chemotherapy 62 Cimzia TM 62 non metastatic osteosarcoma 62 aspirin clopidogrel 62 NVA# 62 daunorubicin 62 Revlimid 62 TNF inhibitor 62 Ophena TM 62 xanthine oxidase inhibitor 62 erlotinib 62 KRAS status 62 Romiplostim 62 Iressa gefitinib 62 oral rivaroxaban 62 strontium ranelate 62 bicalutamide 62 anti androgen 62 dalbavancin 62 CYT# QbG# 62 IMGN# 62 liposomal doxorubicin 62 gemcitabine 62 HuMax CD4 62 ELOXATIN 62 ipilimumab 62 anthracycline taxane 62 natalizumab 62 TriRima 62 TREANDA 62 Gleevec imatinib mesylate 62 lupus nephritis 62 CLARITY study 62 ticagrelor 62 Mepact 62 NATRECOR R 62 vascular disrupting agent 62 Orazol 62 TNF antagonists 62 CINQUIL 62 Erbitux cetuximab 62 aleglitazar 62 plus dexamethasone 62 RSR# 62 OvaRex ® MAb 62 Sym# 62 Arzerra 62 Sprycel 62 Phase 2a trial 62 cangrelor 62 JANUVIA 62 afatinib 62 gemcitabine carboplatin 62 trastuzumab 62 Pegasys plus Copegus 62 Roche Actemra 62 Lapatinib 62 olmesartan 62 Sanofi Aventis Taxotere 62 sorafenib Nexavar ® 62 icatibant 62 Taxotere R 62 Dabigatran 62 etanercept Enbrel 62 mapatumumab 62 GnRH agonists 62 galiximab 62 biologic therapy 62 baminercept 62 crizotinib PF # 62 relapsed refractory multiple myeloma 62 estramustine 62 Genentech Herceptin 62 lumiliximab 62 eribulin 62 everolimus 62 goserelin 62 QVA# 61 GW# [003] 61 Arixtra 61 Sutent sunitinib 61 GALNS 61 Pegintron 61 oxaliplatin Eloxatin 61 alvespimycin 61 Xelox 61 relapsed SCLC 61 anti EGFR antibody 61 adalimumab Humira 61 #I TM# 61 rasagiline 61 Doxil 61 trastuzumab Herceptin ® 61 ImClone Erbitux 61 leukotriene receptor antagonist 61 5-FU/LV 61 FASLODEX 61 anti angiogenic therapy 61 Irinotecan 61 Alemtuzumab 61 phase Ib 61 metaglidasen 61 Aptivus ® 61 tarenflurbil 61 Atrasentan 61 platinum refractory 61 EGFR TKI 61 intensive statin therapy 61 oral methylnaltrexone 61 Removab 61 pain palliation 61 Tarceva erlotinib 61 pegfilgrastim 61 posaconazole 61 midstage clinical 61 resminostat 61 rivaroxaban 61 Clolar ® 61 Celebrex celecoxib 61 carboplatin 61 erlotinib Tarceva ® 61 Trastuzumab 61 GAMMAGARD 61 Virulizin ® 61 calcineurin inhibitors 61 SCCHN 61 MERLIN TIMI 61 tenofovir emtricitabine 61 AVASTIN 61 raloxifene Evista 61 GVAX 61 Inhaled nitric oxide 61 Pfizer Sutent 61 Allovectin 7 61 TAXOTERE R 61 ruboxistaurin 61 lasofoxifene 61 Epivir 61 Gilenia 61 Zybrestat 61 CYPHER Stent 61 Taxotere chemotherapy 61 recurrent glioblastoma 61 nilotinib Tasigna 61 Sunitinib 61 NSABP C 61 MGd 61 pegylated interferon alfa 2b 61 vemurafenib 61 Lenalidomide 61 Liraglutide 61 tecarfarin 61 roflumilast 61 intravenous cyclophosphamide 61 sunitinib Sutent 61 etravirine 61 Bevacizumab 61 oral diclofenac 61 Ceplene/IL-2 61 randomized Phase III 61 Plicera 61 refractory CLL 61 Trabectedin 61 Abiraterone acetate 61 chronic lymphocytic leukemia CLL 61 FTY# fingolimod 61 taxane therapy 61 AMN# [001] 61 fluvastatin 61 tasocitinib 61 cisplatin chemotherapy 61 receptor tyrosine kinase inhibitor 61 VIDAZA 61 Cetuximab 61 eosinophilic asthma 61 pramlintide 61 tipifarnib 61 Nexavar 61 sapacitabine 61 irbesartan 61 Certican 61 Vfend 61 Enzastaurin 61 metastatic malignant 61 vismodegib 61 L MTP PE 61 gp# vaccine 61 vinorelbine 61 Neuvenge 61 sustained virologic response 61 FOLPI 61 relapsed CLL 61 HER2 positive cancers 61 peginterferon alfa 2b 61 FOLFOX4 61 oral clodronate 61 interferon beta 1b 61 cholinesterase inhibitors 61 HGS# 61 Tyrima 61 Everolimus 61 PSMA ADC 61 odanacatib 61 Aromasin 61 Telcyta 61 Pirfenidone 61 virus HCV protease inhibitor 61 gefitinib 61 ibandronate 61 chemotherapy docetaxel 61 fluoropyrimidine 61 FluCAM 61 SUTENT 61 antihypertensive therapy 61 AGILECT R 61 Riluzole 61 Avastin 61 triamcinolone 61 samalizumab 61 nab paclitaxel 61 etanercept 61 pegaptanib 61 JAK inhibitor 61 methotrexate therapy 61 imatinib Gleevec ® 61 bisphosphonate 61 Hydroxyurea 61 Vernakalant 61 denosumab 61 neoadjuvant therapy 61 lacosamide 60 zoledronate 60 Victrelis 60 preoperative chemotherapy 60 paricalcitol 60 rituximab Rituxan 60 surrogate endpoint 60 paclitaxel Taxol R 60 dasatinib Sprycel 60 Leukine 60 APTIVUS r 60 GRN# 60 lenalidomide Revlimid R 60 Tyverb 60 Hepatocellular Carcinoma HCC 60 pegylated interferon alfa 60 adecatumumab 60 antiepileptic drug 60 Rebif ® 60 Proleukin 60 Peginterferon alfa 2b 60 mepolizumab 60 Reverset 60 vidofludimus 60 pioglitazone 60 Halaven 60 rotigotine 60 opioid induced bowel dysfunction 60 insulin glargine 60 phase IIa clinical 60 SCH # 60 mg kg dose 60 tesmilifene 60 Actilon 60 recurrent ovarian cancer 60 Omapro 60 Rilutek 60 dabigatran etexilate 60 Gefitinib 60 DMARD 60 mitoxantrone plus 60 proteasome inhibitor 60 DMARD therapy 60 TDF FTC 60 INCB# [001] 60 Noxafil 60 tumor shrinkage 60 Advexin 60 FOLFIRINOX 60 docetaxel Taxotere ® 60 Gliadel Wafer 60 Laquinimod 60 SUTENT ® 60 sipuleucel T 60 CIMZIA ™ 60 Nexavar ® 60 LUX Lung 60 neoadjuvant chemotherapy 60 Imprime PGG 60 exemestane 60 Cimzia R 60 PROSTVAC TM 60 interferon gamma 1b 60 relapsed multiple myeloma 60 ToGA 60 Satraplatin 60 CANCIDAS 60 PD LID 60 TNF inhibitors 60 muraglitazar 60 SEROQUEL XR 60 Merck KGaA Erbitux 60 motavizumab 60 clodronate 60 pregabalin 60 paclitaxel Taxol 60 phase IIb 60 glatiramer acetate Copaxone 60 low dose cytarabine 60 Teriflunomide 60 zoledronic acid Zometa 60 immunosuppressant drug 60 ISENTRESS 60 paclitaxel Taxol ® 60 EndoTAGTM 1 60 MIRCERA 60 AZILECT 60 APTIVUS R 60 anti TNFs 60 corticosteroid dexamethasone 60 DFMO 60 Combination therapy 60 Velcade 60 IL# PE#QQR 60 Eltrombopag 60 Canvaxin 60 overlapping toxicities 60 pregabalin Lyrica 60 vildagliptin 60 NATRECOR ® 60 anti angiogenic agents 60 SNT MC# 60 RG# [001] 60 lenalidomide Revlimid 60 fondaparinux 60 entinostat 60 velafermin 60 Cabazitaxel 60 Starlix 60 relapsing multiple sclerosis 60 Vectibix panitumumab 60 Rituxan rituximab 60 antithrombotic agents 60 BRIM3 60 bosentan 60 trials RCTs 60 EOquin TM 60 Gemcitabine 60 arzoxifene 60 pamidronate 60 sorafenib Nexavar R 60 MabCampath 60 raltegravir 60 reboxetine 60 CDP# 60 bevacizumab Avastin ® 60 Roche Xeloda 60 Tavocept 60 NXL# 60 Proxinium TM 60 dacarbazine 60 aldosterone antagonists 60 relapsed MCL 60 Triapine 60 relapsed MM 60 picoplatin 60 carfilzomib 60 oxymorphone ER 60 pralatrexate 60 CLL8 60 Phenoptin 60 PTK ZK 60 stage IIIB IV 60 efalizumab 60 Known generically 60 oral antidiabetic 60 cidofovir 60 DMARDs 60 antitumor effect 60 Targretin capsules 60 chronic angina 60 refractory gout 60 Multaq R 60 Etanercept 60 NOXAFIL 60 Neupro R 60 Oxaliplatin 60 intermittent dosing 60 ongoing Phase 1b 60 Neulasta ® 60 ranibizumab 60 RRMS patients 60 farletuzumab 60 INTELENCE 60 aripiprazole Abilify 60 hypomethylating agents 60 albinterferon alfa 2b 60 LAF# 60 Peg IFN 60 Stelara 60 Genentech Rituxan 60 ACUITY trial 60 protease inhibitor PI 60 Abacavir 60 Phase 2b study 60 interferon alfa 2b 60 Roflumilast 60 Crizotinib 60 Mipomersen 60 Genz # 60 AZILECT ® 60 Tanespimycin 60 epirubicin 60 Elidel 60 Vidaza 60 Cloretazine 60 Relovair 60 integrase inhibitor 60 LY# [002] 60 idarubicin 60 Navelbine ® 60 Adalimumab 60 PEG SN# 60 Omnitarg 60 Diamyd ® 60 Zometa zoledronic acid 60 maraviroc 60 tamoxifen Nolvadex ® 60 oxaliplatin 59 FROVA 59 GSK# [001] 59 cinacalcet 59 TYSABRI natalizumab 59 non squamous 59 chemotherapeutic drug 59 Viramidine 59 CIMZIA TM certolizumab pegol 59 ivabradine 59 Azedra 59 Imatinib 59 telcagepant 59 HGS ETR1 59 CBLC# 59 tolvaptan 59 oral FTY# 59 anidulafungin 59 mCRC patients 59 Fingolimod 59 refractory metastatic 59 Zactima 59 Altabax 59 AVADO 59 eplerenone 59 TAXOTERE ® 59 SPRYCEL ® 59 anticancer therapy 59 chemotherapeutic regimen 59 immunotherapeutic agent 59 taranabant 59 Pixuvri 59 VA# [002] 59 rosuvastatin 59 refractory APL 59 methylnaltrexone 59 lomitapide 59 oral prodrug 59 dexpramipexole 59 Phase #/#a 59 placebo controlled Phase 59 5 fluorouracil leucovorin 59 rivastigmine 59 SRT# [003] 59 atorvastatin Lipitor 59 heterozygous FH 59 Maraviroc 59 ILLUMINATE 59 invasive candidiasis 59 sirolimus 59 CA4P 59 Boceprevir 59 clobazam 59 immunosuppressant 59 coxibs 59 heavily pretreated patients 59 chemoradiation 59 UCB Cimzia 59 tacrolimus ointment 59 hormone refractory metastatic prostate 59 Phase IIb trials 59 midstage studies 59 HuMax CD# 59 Invirase 59 adult chronic ITP 59 Novartis Gleevec 59 Reolysin 59 chemotherapeutic agent 59 Paraplatin ® 59 Intuniv 59 Seliciclib 59 alemtuzumab 59 PRT# 59 VEGF inhibitors 59 superficial bladder cancer 59 STRIDE PD 59 daptomycin 59 Catena ® 59 RoActemra 59 Dendreon Provenge 59 COMFORT II 59 aflibercept VEGF Trap 59 ONGLYZA ™ 59 OZURDEX ® 59 selegiline 59 darunavir 59 Celgene Revlimid 59 azathioprine 59 L BLP# 59 Nuvion 59 FOLFIRI alone 59 IIa trial 59 biologic DMARD 59 lintuzumab 59 Folfox 59 MoxDuo IR 59 Elotuzumab 59 adjuvant therapy 59 dexamethasone Decadron 59 liraglutide 59 Degarelix 59 Panzem 59 Phase IIa trial 59 peginterferon alfa 2a 59 anastrazole 59 abacavir lamivudine 59 paliperidone ER 59 Protopic 59 glargine 59 dutasteride 59 fulvestrant 59 candesartan 59 PROCHYMAL 59 OPAXIO 59 Tarceva 59 IV bisphosphonates 59 EVIZON 59 Xeloda capecitabine 59 ZYBRESTAT 59 tolerability profiles 59 safinamide 59 INCB# [002] 59 dose escalation trial 59 registrational trial 59 alvimopan 59 EGFR inhibitors 59 thymalfasin 59 gastrointestinal stromal tumor GIST 59 Tekturna HCT 59 imiquimod cream 59 acyclovir Lauriad R 59 Fludara ® 59 #mg BID [001] 59 lixisenatide 59 cetuximab Erbitux R 59 Amigal 59 mg dose 59 sitagliptin Januvia 59 AEGR 59 elesclomol 59 valsartan 59 plus prednisone 59 tiotropium bromide 59 Cotara 59 Phase Ib clinical 59 metastatic colorectal 59 degarelix 59 metastatic sarcomas 59 Carboplatin 59 Pegylated Interferon 59 SUCCEED trial 59 tofacitinib 59 squamous histology 59 verteporfin 59 Taxol ® 59 cranial radiation 59 phase 2a 59 PROVENGE sipuleucel T 59 Fulvestrant 59 VFEND 59 dose escalation 59 XL# SAR# 59 Rituxan 59 metastatic kidney 59 resistant ovarian cancer 59 risedronate 59 alemtuzumab Campath 59 Tekamlo 59 evaluating T DM1 59 ARIMIDEX 59 assessing T DM1 59 anthracyclines taxanes 59 HQK 59 Gemzar ® 59 RSD# oral 59 TriLipix 59 mTOR inhibitors 59 NLX P# 59 rilonacept 59 MabThera Rituxan 59 administered subcutaneously 59 venous thromboembolic events 59 nonrandomized 59 COREG 59 metastatic malignant melanoma 59 EFAPROXYN 59 CUSTOM III 59 gemifloxacin 59 long acting bronchodilator 59 Muraglitazar 59 Mitoxantrone 59 REYATAZ R 59 myelodysplastic syndromes 59 Exemestane 59 ALGRX 59 Alimta pemetrexed 59 leukotriene receptor antagonists 59 randomized discontinuation trial 59 #mg dose [003] 59 OMAPRO 59 TH# [003] 59 investigational compound 59 metastatic colorectal carcinoma 59 bezafibrate 59 DASISION 59 FOLPI regimen 59 Tesmilifene 59 pegylated interferon peg IFN 59 Humira adalimumab 59 Topotecan 59 Camptosar ® 59 imatinib 59 pentoxifylline 59 eculizumab 59 #mg dose [001] 59 desvenlafaxine 59 Gleevec Glivec 59 5FU 59 trastuzumab DM1 59 talactoferrin 59 Exforge HCT 59 DOXIL 59 randomized controlled clinical trials 59 DACH platinum 59 5 Fluorouracil 59 Betaferon 59 antithrombotics 59 Hodgkin lymphoma HL 59 Thal Dex 59 orBec 59 differentiated thyroid 59 OHR/AVR# 59 SAR# [004] 59 ATACAND 59 dirucotide 59 cytotoxic chemotherapy 59 rALLy clinical trial 59 Phase 1b 59 recurrent NSCLC 59 febuxostat 59 CYC# 59 Tocosol Paclitaxel 59 SCIg 59 Amplimexon 59 ezetimibe Zetia 59 HRPC 59 NEVO ™ 59 torezolid phosphate 59 alefacept 59 PRECiSE 59 Afatinib 59 Saphris 59 Selzentry 59 VEGF Trap 59 Telintra 59 placebo controlled trials 59 evaluating Xcytrin 59 abacavir Ziagen 59 octreotide LAR 59 insulin sensitizers 59 AP# [003] 59 Protelos 59 Syncria 59 fibrinolytic 59 cytokine refractory